CASPASE INHIBITOR AND PHARMACEUTICAL COMPOSITION, USE AND THERAPEUTIC METHOD THEREOF
申请人:Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
公开号:US20190135733A1
公开(公告)日:2019-05-09
Disclosed are a class of compounds as a caspase inhibitor, and in particular the compound as shown in formula (I) or a pharmaceutically acceptable salt thereof, and the use of the compound in treating caspase-related diseases.